Business
Why the Neuren (ASX:NEU) share price is moving higher today
Neuren Pharmaceuticals Ltd (ASX: NEU) shares are trending higher in early afternoon trade. This comes after the biotech company announced it has successfully completed manufacturing a drug substance for its Phase 2 trials.
At the time of writing, the Neuren share price has jumped to an intraday high of $1.28, up 1.99% for the day so far.
What did Neuren announce?
The Neuren share price is edging higher as investors appear pleased with the company’s progress.
According to its release, Neuren’s second drug candidate, NNZ-2591, has been manufactured ahead of Phase 2 trials. The company is currently preparing to submit Investigational New Drug…
-
Noosa News18 hours agoNRL live updates: Newcastle Knights vs Melbourne Storm, St George Illawarra Dragons vs Sydney Roosters, North Queensland Cowboys vs Canterbury Bulldogs
-
Noosa News19 hours ago‘Shocked’ Labor calls in corruption watchdog over CFMEU report
-
Noosa News19 hours agoCreating space for cultural pride – Proctor
-
Noosa News22 hours agoNASAA Certified Organic collapse threatens export capabilities for hundreds of Australian producers